The risk of venous thromboembolism (VTE) is increased in cancer patients. To improve
prediction of VTE in cancer patients, we performed a prospective and observational cohort …

Cancer patients are at increased risk of deep vein thrombosis and pulmonary embolism. The
incidence among different groups of cancer patients varies considerably depending on …

Purpose Patients with cancer are increasingly at risk for venous thromboembolism (VTE).
Rates of VTE, however, vary markedly among patients with cancer. Design This review …

Background. Retrospective studies have suggested an association between cancer-
associated venous thromboembolism (VTE) and patient survival. We evaluated a previously …

Background Venous thromboembolism is a common complication of cancer, but the risk of
developing venous thromboembolism varies greatly among individuals and depends on …

In ambulatory patients with solid cancer, routine thromboprophylaxis to prevent venous
thromboembolism is not recommended. Several risk prediction scores to identify cancer …

Cancer-associated venous thromboembolism (VTE) has major consequences for patients,
including morbidity and risk of mortality. However, there is substantial variation in risk …

Background: Cancer patients of the Department of Internal Medicine (Cancer Research) of
the Essen University Medical School (Tumor Clinics), Germany, were examined and …

Purpose Patients with cancer are at increased risk of venous thromboembolism (VTE).
Laboratory tests measuring the overall thrombophilic tendency might be useful to assess …

Cancer and its treatments are well-recognized risk factors for venous thrombo-embolism
(VTE). Although solid tumors have historically been associated with VTE, more recent data …